Check if your research matches the topics covered in Expert Opinion on Emerging Drugs?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Researcher.Lifeは、エディテージが20年以上にわたる研究者の皆様との深い関わりの中で蓄積した、出版や研究活動の「あったらいいな」を詰め込んだプラットフォームです。
Expert Opinion on Emerging Drugs is a quarterly peer-reviewed medical journal publishing structured reviews on drugs/drug classes emerging onto the market across all therapy areas. Each review includes an "expert opinion" section, in which authors are asked to provide their personal view on the current status and future direction of the research discussed. It was established as Emerging Drugs in 1996, changing to its current name in 2001. It is published by Informa. According to the Journal Citation Reports, the journal has a 2014 impact factor of 3.058. Less
Overview | |
Publisher | TAYLOR & FRANCIS LTD |
Language | English |
Frequency | Quarterly |
General Details | |
Language | English |
Frequency | Quarterly |
Publication Start Year | 2001 |
Publisher URL | Visit website |
Website URL | Visit website |
Upload your Manuscript to get
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
Expert Opinion on Emerging Drugs has been in operation since 2001 till date.
Expert Opinion on Emerging Drugs published with a Quarterly frequency.
In 2023, Expert Opinion on Emerging Drugs publsihed 29 articles.
For Expert Opinion on Emerging Drugs, eISSN is 1744-7623 and pISSN is 1472-8214.
Citescore for Expert Opinion on Emerging Drugs is 5.6.
H Index for Expert Opinion on Emerging Drugs is 52.
SNIP score for Expert Opinion on Emerging Drugs is 0.8.
SJR for Expert Opinion on Emerging Drugs is Q1.
TAYLOR & FRANCIS LTD is the publisher of Expert Opinion on Emerging Drugs.